Multicentre double-blind randomized controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery
Senanayake, E. L., Howell, N. J., Ranasinghe, A. M., Drury, N. E., Freemantle, N., Frenneaux, M., Oelofse, T., Green, D., Wilson, I. C., Rooney, S. J., Mascaro, J., Graham, T. R., Bhudia, S., Lewis, MLanguage:
english
Journal:
European Journal of Cardio-Thoracic Surgery
DOI:
10.1093/ejcts/ezu452
Date:
December, 2014
File:
PDF, 251 KB
english, 2014